Medication info
Rivaroxaban High Tablet 4/80/5 mg (Pitavastatin Calcium Hydrate, Valsartan, Amlodipine Besylate)

Rivaroxaban High Tablet 4/80/5 mg (Pitavastatin Calcium Hydrate, Valsartan, Amlodipine Besylate)

Prescription medicationTabletOral
Ingredient · strength
Valsartan›80mg / 1 tabletAmlodipine Besylate›6.94mg / 1 tabletPitavastatin Calcium Hydrate›4.409mg / 1 tablet
Manufacturer / importer
JW Pharmaceutical Corp.
Appearance
Dark pink round film-coated tablets
Packaging
30 tablets/PVC [6 tablets/PVC x 5]
Approval status
Active

MFDS item code 202502535 · Approved 2025.09.24 · Insurance code 644915450

Summary

Main use
Treatment of primary hypercholesterolemia, mixed dyslipidemia, and essential hypertension
Who takes it
Adults
Adult dose
Take 1 tablet once daily with water. It is recommended that the medicine be taken at the same time each day, if possible (e.g., before breakfast). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/valsartan combination and pitavastatin. Patients taking the amlodipine/valsartan combination and pitavastatin as separate medicines may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. ▷ Amlodipine/valsartan combination It is recommended that the dose of each individual component (amlodipine or valsartan) be adjusted before administering the amlodipine/valsartan combination. However, a direct switch to the amlodipine/valsartan combination may be considered if blood pressure is not controlled with monotherapy using either component, as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients with renal impairment: No dosage adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 10mL/min or greater). Do not administer the amlodipine/valsartan combination to patients with severe renal impairment (creatinine clearance less than 10mL/min) or to patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, the daily dose of valsartan must not exceed 80mg. Do not administer the amlodipine/valsartan combination to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years and older: Use caution when increasing the dose. ▷ Pitavastatin Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The usual initial dose for adults is 1~2 mg of pitavastatin calcium once daily. If the reduction in LDL cholesterol is inadequate, the dose may be increased to a maximum of 4 mg daily. Adjust the dose as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goal, and patient's response. The therapeutic effect of this medicine is maintained with continued administration.

Ingredients

Manufacturer
JW Pharmaceutical Corp.

Efficacy & effects

Treatment of primary hypercholesterolemia, mixed dyslipidemia, and essential hypertension

  • Essential hypertension
  • primary hypercholesterolemia
  • dyslipidemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated apo-B protein
  • elevated triglyceride levels
View approved original text

This medication is used for patients with essential hypertension whose blood pressure is not adequately controlled by taking amlodipine and valsartan together, and who also need to take pitavastatin. Amlodipine and valsartan help lower blood pressure, while pitavastatin is effective in controlling cholesterol levels by improving hypercholesterolemia and dyslipidemia. This medication is used to improve cardiovascular health by managing blood pressure and blood lipids simultaneously.

How to take

Adult dose

Take 1 tablet once daily with water. It is recommended that the medicine be taken at the same time each day, if possible (e.g., before breakfast). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/valsartan combination and pitavastatin. Patients taking the amlodipine/valsartan combination and pitavastatin as separate medicines may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. ▷ Amlodipine/valsartan combination It is recommended that the dose of each individual component (amlodipine or valsartan) be adjusted before administering the amlodipine/valsartan combination. However, a direct switch to the amlodipine/valsartan combination may be considered if blood pressure is not controlled with monotherapy using either component, as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients with renal impairment: No dosage adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 10mL/min or greater). Do not administer the amlodipine/valsartan combination to patients with severe renal impairment (creatinine clearance less than 10mL/min) or to patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, the daily dose of valsartan must not exceed 80mg. Do not administer the amlodipine/valsartan combination to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years and older: Use caution when increasing the dose. ▷ Pitavastatin Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The usual initial dose for adults is 1~2 mg of pitavastatin calcium once daily. If the reduction in LDL cholesterol is inadequate, the dose may be increased to a maximum of 4 mg daily. Adjust the dose as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goal, and patient's response. The therapeutic effect of this medicine is maintained with continued administration.

Precautions

This medication may cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so women who are pregnant or may become pregnant should not use this medication. Additionally, individuals who are allergic to any of the components or similar medications, those with severe liver impairment, severe kidney impairment, or active liver disease should avoid taking this medication. Patients with sodium or fluid deficiency should stabilize their condition before starting this medication and monitor blood pressure and symptoms closely during treatment. If there is hyperkalemia or if other medications that can elevate potassium levels are being taken, potassium levels should be checked frequently. Patients with compromised kidney function or renal artery stenosis require careful monitoring due to the risk of worsening kidney function. Patients with heart failure or after a myocardial infarction should closely monitor changes in kidney function and blood pressure when taking this medication, especially if heart failure is severe. This medication can lower blood pressure, so caution is needed in patients with hypotension or severe aortic stenosis. Some components of this medication are metabolized in the liver, so patients with reduced liver function may require dose adjustments and should undergo regular liver function tests. Muscle pain, weakness, or in severe cases muscle damage known as rhabdomyolysis may occur, so if these symptoms appear, patients should consult with a doctor immediately. During the use of this medication, side effects such as headache, dizziness, edema, and dyspepsia may occur, so if symptoms are severe or persistent, patients should inform healthcare providers. Caution is necessary when driving or operating machinery as dizziness or fatigue may occur. This medication may interact with other drugs, so it is important to inform healthcare providers about any other medications being taken. Women who are pregnant or breastfeeding should not take this medication, and if pregnancy is confirmed while taking it, treatment should be stopped immediately. Elderly patients may be more sensitive to this medication, so starting with a lower dose and careful monitoring of their condition is advised. In case of an overdose, severe blood pressure drop or shock may occur, so adherence to the prescribed dosage is crucial, and immediate emergency treatment is needed if unusual symptoms arise. This medication should be kept out of the reach of children and stored in its original container to prevent misuse or deterioration in quality.

Side effects

  • COVID-19
  • nasopharyngitis
  • systemic edema
  • peripheral edema
  • elevated creatine kinase levels
  • headache
  • itching
  • sudden hearing loss
  • intestinal stricture
  • double vision
Show 134 more
  • thrombocytopenia
  • leukopenia
  • allergic reactions
  • hyperglycemia
  • insomnia
  • mood changes
  • tremors
  • sensory alterations
  • dysgeusia
  • peripheral neuropathy
  • excessive muscle tension
  • arrhythmia
  • bradycardia
  • atrial fibrillation
  • ventricular tachycardia
  • myocardial infarction
  • vasculitis
  • dyspnea
  • rhinitis
  • vomiting
  • dyspepsia
  • pancreatitis
  • gastritis
  • gingival hyperplasia
  • hepatitis
  • jaundice
  • alopecia
  • purpura
  • skin depigmentation
  • photosensitivity reactions
  • angioedema
  • urticaria
  • erythema multiforme
  • Stevens-Johnson syndrome
  • myalgia
  • urination disorders
  • nocturia
  • gynecomastia
  • pain
  • fatigue
  • chest pain
  • weight loss
  • weight gain
  • decreased hemoglobin
  • decreased hematocrit
  • neutropenia
  • thrombocytopenia
  • serum sickness
  • elevated serum potassium
  • vascular edema
  • vesicular dermatitis
  • myalgia
  • renal failure
  • renal damage
  • elevated serum creatinine
  • insomnia
  • decreased libido
  • pharyngitis
  • rhinitis
  • sinusitis
  • upper respiratory tract infection
  • viral infection
  • rhabdomyolysis
  • myopathy
  • hepatic dysfunction
  • jaundice
  • thrombocytopenia
  • urticaria
  • rash
  • erythema
  • angioedema
  • elevated bilirubin
  • increased cholinesterase
  • elevated AST
  • elevated ALT
  • elevated γ-GT
  • elevated ALP
  • elevated LDH
  • rigidity
  • drowsiness
  • heavy head
  • paralysis
  • dizziness
  • thirst
  • abdominal pain
  • abdominal distension
  • constipation
  • stomatitis
  • decreased appetite
  • glossitis
  • nausea
  • gastric discomfort
  • diarrhea
  • hypersensitivity
  • skin tingling
  • elevated blood pressure
  • chest discomfort
  • weakness
  • increased LDH
  • increased ALP
  • facial edema
  • arm edema
  • palpitations
  • fatigue
  • skin pain
  • burning sensation
  • arthralgia
  • edema
  • blurred vision
  • photophobia
  • hearing loss
  • hematuria
  • elevated uric acid levels
  • elevated serum potassium and phosphorus
  • dysgeusia
  • colored urine
  • lifestyle fatigue
  • positive ANA
  • hair loss
  • sleep disorders
  • memory loss
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • decreased aldosterone
  • increased aldosterone
  • increased ACTH
  • increased cortisol
  • decreased testosterone
  • muscle cramps
  • elevated serum myoglobin
  • increased CPK
  • muscle pain
  • weakness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored at room temperature between 1 and 30 degrees Celsius, and it is important to keep it in a well-closed container to prevent air exposure. This helps to maintain the effectiveness of the medication and prevent degradation.

Appearance and packaging

Appearance

Dark pink round film-coated tablets

Package unit

30 tablets/PVC [6 tablets/PVC x 5]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.